Precise Biometrics Q1 report was more or less as expected. Sales came in at SEK 9m vs. our expectations of SEK 8m. Also the gross margin was decent. On the other hand, since the Company had some currency losses and the general cost base was slightly high, the EBIT-figure came in somewhat worse than expected at SEK -11m vs. SEK -7m. Looking forward, the Company’s CEO was still very optimistic about the prospects for 2008. The reasons for this are: good pipeline of software oriented deals, large order in 2008 from SUS (somewhat delayed), ramp up of the OKI-deal in Q2 and two-four more NID-project during 2008. We have trimmed our estimates downwards slightly. After only SEK 26m in the cash balance we see a risk of a share issue in the next 3-12 months.